(Q43779719)

26 November 2017

0 references

Tyrosine kinase inhibitor imatinib (STI571) as an anticancer agent for solid tumours (English)

1 reference

26 November 2017

1 reference

Joensuu H

1

1 reference

PubMed ID

11680792

26 November 2017

Dimitrijevic S

series ordinal

2

1 reference

PubMed ID

11680792

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

26 November 2017

1 reference

26 November 2017

33

1 reference

26 November 2017

451-455

1 reference

26 November 2017

7

1 reference

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

26 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002093

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002093

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002093

Gastrointestinal stromal tumors: their origin and cause

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002093

Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002093

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002093

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002093

ZD1839 ('Iressa') as an anticancer agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002093

10.3109/07853890109002093

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference

PubMed ID

11680792